Diabetes drug, Mounjaro,launched in India
Mounjaro (tirzepatide), a breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization (CDSCO). In a groundbreaking development, Eli Lilly and Company has announced that its drug, tirzepatide (Mounjaro), significantly reduces the risk of developingContinue Reading